Antibiotic resistance of campylobacteria in St. Petersburg


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Campylobacter is the leading hemorrhagic colitis and one of the most common bacterial infections in all regions of the world. In the extensive practice of practical medicine, the appointment of antibacterial drugs for campylobacteriosis is considered. This is of particular importance in the growing amount of data on the increased resistance of campylobacter to antimicrobial effects and the rapid spread of resistant strains in food and the environment. Objective. Evaluation of the antibiotic resistance level of Campylobacter spp. Methods. 50 patients with manifest forms of campylobacteriosis were examined. The phenotypic profiles of antibiotic resistance of 54 strains of Campylobacter jejuni and Campylobacter coli isolated from patients with manifest forms of the disease were studied. The sensitivity of the isolated strains to 10 antimicrobial drugs of 8 pharmacological groups (erythromycin, ciprofloxacin, nalidixic acid, gentamicin, amikacin, tetracycline, doxycycline, ampicillin, chloramphenicol, and cefotaxime) was determined by the disc diffusion method. Results. Most of the tested Campylobacter spp. strains were resistant to nalidixic acid and tetracycline. The frequency of isolation of strains resistant to macrolides and fluoroquinolones was 11.1 and 16.7%, respectively; 14.8% of isolates were multiresistant to 4 or more antibiotics. The obtained data indicate a high prevalence of antibiotic-resistant strains among campylobacteria isolated from patients with manifest forms of the disease. According to the study, risk factors for infection with resistant strains of Campylobacter spp. Included overseas travel to the Asian region and eradication therapy. Conclusion. The results of the study confirm the need for further evaluation of the formation of antibiotic resistance of Campylobacter spp. based on the determination of genetic profiles and intracellular mechanisms of expression of other pathogenic factors.

Full Text

Restricted Access

About the authors

K. D Ermolenko

Children's Research and Clinical Center for Infectious Diseases FMBA of Russia

Email: ermolenko.kd@yandex.ru
Cand. Sci. (Med.), Researcher at the Department of Intestinal Infections

T. V Potapova

Pavlov University; S.P. Botkin Clinical Hospital for Infectious Diseases

References

  1. Kaakoush N.O., Castano-Rodrfguez N., Mitchell H.M., Man S.M. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015;28(3):687-720. Doi: 10.1128/ CMR.00006-15.
  2. Гончар Н.В., Ермоленко К.Д., Климова О.И. и др. Бактериальные кишечные инфекции с синдромом гемоколита у детей: этиология, лабораторная диагностика (обзор). Медицина экстремальных ситуаций. 2019;21(1):92-104.
  3. Maue A.C., Poly F., Guerry P. A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni. Human Vaccin Immunother. 2014;10(6):1499-504. doi: 10.4161/hv.27985.
  4. Потапова Т.В., Лиознов Д.А., Драп А.С., Ермоленко К.Д. Эпидемиологические и клинико-лабораторные аспекты кампилобактериоза. Фарматека. 2017;5(13):40-43.
  5. Wakerley B.R., Uncini A., Yuki N., et al. Guillain-Barre and Miller Fisher syndromes - new diagnostic classification. Nat Rev Neurol. 20I4;I0(9):537. doi: 10.1038/nrneurol.2014.138.
  6. Ермоленко К.Д., Гончар Н.В., Ермоленко Е.И., Лобзин Ю.В. Нарушение микробиоценоза кишечника как фактор формирования постинфекционной патологии органов пищеварения у детей после вирусных кишечных инфекций. Экспериментальная и клиническая гастроэнтерология, 2017;1(137):53-57.
  7. Piescik-Lech M.,Shamir R., Guarino A.,Szajewska H. The management of acute gastroenteritis in children. Aliment Pharmacol Ther. 2013;37(3):289-303. doi: 10.1111/apt.12163.
  8. Ермоленко К.Д., Мартенс Э.А., Болдырева Н.П., Ермоленко Е.И. Рациональная терапия кампилобактериоза у детей. Фарматека, 2019;26(10):40-4. Doi: 10.18565/ pharmateca.2019.10.40-44. doi: 10.18565/pharmateca.2019.10.40-44
  9. Smith K.E., Besser J.M., Hedberg C.W., et al. Quinolone-Resistant Campylobacter jejuni Infections in Minnesota, 1992-1998. N. Engl J. Med. 1999;340(20):1525-32. Doi: 10.1056/ NEJM199905203402001.
  10. Ефимочкина Н.Р., Короткевич Ю.В., Стеценко В.В. и др. Антибиотикорезистентность штаммов Campylobacter jejuni, выделенных из пищевых продуктов. Вопросы питания. 2017;86(1):17-
  11. Serichantalergs O., Dalsgaard A., Bodhidatta L., et al. Emerging fluoroquinolone and macrolide resistance of Campylobacter jejuni and Campylobacter coli isolates and their serotypes in Thai children from 1991 to 2000. Epidemiol Infect. 2007;135(8):1299-306. Doi: 10.1017/ S0950268807008096.
  12. Lynch C., Lynch H., Egan J., et al. Antimicrobial resistance of Campylobacter isolates recovered from broilers in the Republic of Ireland in 2017 and 2018: An update. Br Poultr Sci. 2020;61(5):550-56. doi: 10.1080/00071668.2020.1758300.
  13. Rao D., Rao J., Crothers E., McMullan R., et al. Increased erythromycin resistance in clinical Campylobacter in Northern Ireland-an update. J. Antimicrob Chemother. 2005;55(3):395-96. doi: 10.1093/jac/dkh552.
  14. Gupta A., Nelson J.M., Barrett T.J., et al. Antimicrobial resistance among campylobacter strains, United States, 1997-2001. Emerg Infect Dis. 2004;10(6):1102-109. Doi: 10.3201/ eid1006.030635.
  15. Gaunt P., Piddock L.J. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J. Antimicrob Chemother. 1996;37(4):747-57. Doi: 10.1093/ jac/37.4.747.
  16. Alfredson D.A., Korolik V. Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli. FEMS Microbiol Lett. 2007;277(2):123-32. doi: 10.1111/j.1574-6968.2007.00935.x.
  17. Gibreel A., Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob Chemother. 2006;58(2):243-55. doi: 10.1093/jac/dkl210.
  18. Тазалова Е.В. Чувствительность кампилобактерий к антибиотикам и некоторые механизмы формирования антибиотикорезистентности. Дальневосточный медицинский журнал. 2012(3):120-3.
  19. Oyarzabal O.A., Rad R., Backert S. Conjugative transfer of chromosomally encoded antibiotic resistance from Helicobacter pylori to Campylobacter jejuni. J. Clin Microbiol. 2007;45(2):402-8. doi: 10.1128/JCM.01456-06.
  20. Engberg J., Neimann J., Nielsen E.M., et al. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis. 2004;10(6):1056. Doi: 10.3201/ eid1006.030669.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies